KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹37 Cr | ₹33 Cr | ₹33 Cr | ₹33 Cr | ₹34 Cr |
What is the latest Total Non-Current Liabilities ratio of KOPRAN ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹37 Cr |
| Mar2024 | ₹33 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹33 Cr |
| Mar2021 | ₹34 Cr |
How is Total Non-Current Liabilities of KOPRAN Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹37 Cr | 9.64 | |
| Mar2024 | ₹33 Cr | -0.03 | |
| Mar2023 | ₹33 Cr | 1.05 | |
| Mar2022 | ₹33 Cr | -1.59 | |
| Mar2021 | ₹34 Cr | - | |
Compare Total Non-Current Liabilities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹931.7 Cr | 1.6% | 5.4% | 4.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | 1.6% |
5.4% |
4.7% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses